Verition Fund Management’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,542
Closed -$217K 3018
2022
Q3
$217K Buy
20,542
+459
+2% +$4.88K ﹤0.01% 2447
2022
Q2
$186K Buy
20,083
+83
+0.4% +$679 ﹤0.01% 1971
2022
Q1
$138K Hold
20,000
﹤0.01% 2405
2021
Q4
$161K Buy
20,000
+10,000
+100% +$66.4K ﹤0.01% 2278
2021
Q3
$61K Hold
10,000
﹤0.01% 1761
2021
Q2
$31K Hold
10,000
﹤0.01% 1824
2021
Q1
$38K Hold
10,000
﹤0.01% 1487
2020
Q4
$31K Hold
10,000
﹤0.01% 1050
2020
Q3
$23K Hold
10,000
﹤0.01% 1019
2020
Q2
$103K Hold
10,000
﹤0.01% 1000
2020
Q1
$100K Buy
+10,000
New +$89.1K ﹤0.01% 529

Other funds holding BLU

Verition Fund Management's BLU Position: Q4 2022 in Review

Verition Fund Management sold out of BELLUS Health Inc. (BLU) in Q4 2022, closing a stake of 20,542 shares — an estimated $217K sold.

Verition Fund Management first reported a position in BLU in Q1 2020 and held it in 11 quarters. The position peaked at $217K in Q3 2022. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • Verition Fund Management reported no remaining BELLUS Health Inc. position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 20,542 BELLUS Health Inc. shares in Q4 2022, an estimated $217K.
  • Verition Fund Management first reported a position in BELLUS Health Inc. in Q1 2020 and held it in 11 quarters.
  • Verition Fund Management's BELLUS Health Inc. position peaked at $217K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.